President Trump recently called the marijuana policy “A lot of complex“while he was”Listened to great things“About medical marijuana.
He both matters – the medical canbis policy is complex, but the benefits are undisputed. With the right leadership, this is a challenge.
He is not alone in this scene. Former representative Bob Barr (R-Ga.), Which onceBlockedWashington, DC, by implementing medical canbis laws, recentlyArguedThe status of marijuana as a schedule I drug “creates major obstacles for researchers and doctors,” and the idea that the cannabis has “no known medical use”, “clearly old”.
Barr said that cutting red tape will support hundreds of thousands of jobs and will carry forward medical successes.
Just a few weeks ago, AAligning of more than 40 patient organizations(Including my organization), representing tens of millions of Americans, urged the policies in an open letter to maintain security for medical programs, called medical marijuana programs “a lifeline for millions of Americans”.
The letter was called for the “comprehensive, permanent federal law”, which “aligns the federal cannabis policy with the state laws and integrates the medical cannabis in the mainstream healthcare,” and urges the maintenance of the medical canbis amendment.Commerce, Justice, Science and Related Agencies Bills,
If the drug enforcement agency follows the Department of Health and Human Services’RecommendationTo transfer canbis to schedule iii, it will be easy and less expensive for researchers to study medical applications.
Association of American Medical College and Council on Government RelationsWhereRescheduling “will provide the facility of researchers to do research using marijuana, as Schedule III compliance with security requirements is less cumbersome than people associated with Schedule I matter, while still needed responsible storage and safety protocols.”
This can reduce stigma and promote greater acceptance between physicians, employers and policy makers.
But the re -radiation alone will not correct systemic challenges in front of patients or businesses. Schedule III, in itself, will not “legal” the cannabis occupations received under the federal law, upgrade the design of the state program, or restore federal rights for patients.
The state medical canbis program, which is currently protected by federal intervention by Commerce, Justice and Science Appropriation Amendment, will continue to rely on the Congress to renew those security each year.
Unlike the anti -marijuana and publicly trading cannabis companies, IRS rules will still prevent canbis companies from cutting ordinary business expenses without a change.Federal lawDespite Schedule III, abolishing the application of some tax code.
These rules still remain, even though the government shows its own research that medical marijuana is safe and effective. Food and Drug Administration Center for Drug Evolution and ResearchHas foundAny “adequate safety concerns that will argue against the use of marijuana in any indication, where there is some support for its benefit.”
Those benefits are not imaginary – they are already changing life.
Who are those patients? Large adults are one of the fastest growing groups- One of 5 Americans is 50-80 years old Used canbis in the last one year, often for pain or sleep. National survey of american lejan It was found that 22 percent of the veterans reported using cannabis for conditions such as chronic pain, post-tracts disorder and sleep problems.
studies show In three out of 10 patients with chronic pain, canbis is used to manage pain and improve daily functions, often less or replaced by opioid remedies. The Center for Disease Control and Prevention estimates that in 2021, 51.6 millionAmerican adults lived with chronic pain.
Meanwhile, chronic disease drive 90 percent of the country’s $ 4.9 trillionIn annual health care expenses. Many of these conditions are poorly served by existing drugs. Cannabis-based therapy provides multi-scarcity, multi-protection relief, often with less risks than other drugs, yet the federal policy consider the canbis as a control.
At the end, More than 40 percentCannabis is used for sleep, mood, stress, anxiety, depression and pain in patients suffering from cancer. These are not fringe populations.
Trump in his first term dealt with Opioid epidemic with a signature priority. Research suggests that cannabis can be part of the access solution. Washington Post recentlyOP-Ed In short new data: Counties with cannabis dispensary dropped the opioid mortality of about 30 percent within 10 years of opening their first dispensary.
This is a public health result that no policy maker should ignore.
Furthermore, without federal reforms, American global medicine takes the risk of losing its place in the cannabis market. About 60 countriesAlready there are national programs, patients offer standardized, drug-grade canbis products.
American companies, stuck in a patchwork of state laws and blocked inter -state commerce, cannot compete globally. This refutes the “Made in the USA in the USA” commitment for domestic manufacturing and innovation.
Although the President Can not only legalize the cannabisBy executive order, what he can do here:
- End the renovation. He can direct the DEA Administrator Terence Coal whether he can eliminate the rules by adopting the Schedule III recommendation of HHS through the final rule or can immediately solve the pendingAdministrative Law Judge issueAnd proceed to a determination.
- Stop the knee of Congress.He may urge to remove the dishonor Section 607Commerce, Justice and Science Appropriation Bill, which prohibit the use of Appropriation Fund for Merijuana reinstated and danger state medical-program protection.
- Pull the sharpie out: He can create an office of medical cannabis and canbinoid control In HHS, As the model is mentioned in the lawMy organization is designed for safe access by Americans. He can also help eliminate the eviction of medical cannabis patients in federal housing, allowing VA doctors to recommend abolishing cannabis and canbis drug tests for federal employees.
- Create a real medical passage.He may ask the Congress to pass the bilateral medical canbis law that inspects in the office of the medical canbis and makes a dedicated cannabis schedule (make it a schedule VI call) aligned with the treaty obligations. In this way we support patients, science and American manufacturers at a time.
The medical canbis policy is, in fact, very complex. But it is also mature for a bold, disruptive success, exactly the same challenge that President Trump has created his brand. Millions of patients, hundreds of thousands of jobs, and the US position in a global development industry hangs in balance.
Identify the current accepted medical use of cannabis, protect patients and create a serious federal structure that allows American companies to innovate and practice medical professionals. This is a disruption with a purpose.
Step Sherler is the founder and president of Americans for safe access.
